科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2020/05/13 | 5,740 | 5,770 | 5,670 | 5,750 | -70 | -1.2% | 225,200 |
| 2020/05/12 | 5,790 | 5,910 | 5,770 | 5,820 | +60 | +1% | 209,600 |
| 2020/05/11 | 5,780 | 5,790 | 5,560 | 5,760 | +20 | +0.3% | 280,000 |
| 2020/05/08 | 6,150 | 6,150 | 5,680 | 5,740 | -420 | -6.8% | 730,600 |
| 2020/05/07 | 6,230 | 6,410 | 6,060 | 6,160 | +330 | +5.7% | 894,800 |
| 2020/05/01 | 5,940 | 5,960 | 5,800 | 5,830 | -80 | -1.4% | 157,100 |
| 2020/04/30 | 5,960 | 6,100 | 5,890 | 5,910 | -10 | -0.2% | 260,400 |
| 2020/04/28 | 5,760 | 5,930 | 5,760 | 5,920 | +120 | +2.1% | 119,800 |
| 2020/04/27 | 5,990 | 6,000 | 5,760 | 5,800 | -120 | -2% | 217,500 |
| 2020/04/24 | 5,840 | 5,920 | 5,770 | 5,920 | +80 | +1.4% | 129,200 |
| 2020/04/23 | 5,840 | 5,900 | 5,760 | 5,840 | +10 | +0.2% | 153,800 |
| 2020/04/22 | 5,730 | 5,850 | 5,690 | 5,830 | +130 | +2.3% | 164,800 |
| 2020/04/21 | 5,610 | 5,730 | 5,560 | 5,700 | +160 | +2.9% | 173,500 |
| 2020/04/20 | 5,580 | 5,610 | 5,500 | 5,540 | -130 | -2.3% | 152,700 |
| 2020/04/17 | 5,760 | 5,800 | 5,620 | 5,670 | -80 | -1.4% | 171,400 |
| 2020/04/16 | 5,750 | 5,860 | 5,690 | 5,750 | +40 | +0.7% | 236,000 |
| 2020/04/15 | 5,700 | 5,720 | 5,610 | 5,710 | -40 | -0.7% | 240,900 |
| 2020/04/14 | 5,810 | 5,880 | 5,710 | 5,750 | -60 | -1% | 152,600 |
| 2020/04/13 | 5,710 | 5,930 | 5,650 | 5,810 | +110 | +1.9% | 220,500 |
| 2020/04/10 | 5,630 | 5,720 | 5,520 | 5,700 | +100 | +1.8% | 152,000 |
| 2020/04/09 | 5,670 | 5,840 | 5,520 | 5,600 | +30 | +0.5% | 273,300 |
| 2020/04/08 | 5,540 | 5,770 | 5,520 | 5,570 | +70 | +1.3% | 295,800 |
| 2020/04/07 | 6,100 | 6,130 | 5,360 | 5,500 | +200 | +3.8% | 539,000 |
| 2020/04/06 | 5,170 | 5,340 | 5,150 | 5,300 | +190 | +3.7% | 198,700 |
| 2020/04/03 | 5,010 | 5,220 | 5,010 | 5,110 | +175 | +3.5% | 199,300 |
| 2020/04/02 | 4,870 | 5,010 | 4,825 | 4,935 | +70 | +1.4% | 108,000 |
| 2020/04/01 | 5,010 | 5,110 | 4,850 | 4,865 | -165 | -3.3% | 158,900 |
| 2020/03/31 | 5,170 | 5,280 | 4,995 | 5,030 | -110 | -2.1% | 156,600 |
| 2020/03/30 | 4,970 | 5,140 | 4,845 | 5,140 | +50 | +1% | 201,600 |
| 2020/03/27 | 4,945 | 5,090 | 4,930 | 5,090 | +285 | +5.9% | 241,200 |
| 2020/03/26 | 4,755 | 4,865 | 4,665 | 4,805 | -90 | -1.8% | 204,100 |
| 2020/03/25 | 4,800 | 4,925 | 4,775 | 4,895 | +220 | +4.7% | 189,100 |
| 2020/03/24 | 4,620 | 4,715 | 4,565 | 4,675 | +140 | +3.1% | 246,800 |
| 2020/03/23 | 4,575 | 4,640 | 4,370 | 4,535 | +240 | +5.6% | 354,300 |
| 2020/03/19 | 4,020 | 4,335 | 3,995 | 4,295 | +385 | +9.8% | 337,700 |
| 2020/03/18 | 4,110 | 4,200 | 3,905 | 3,910 | -170 | -4.2% | 236,600 |
| 2020/03/17 | 3,995 | 4,145 | 3,920 | 4,080 | -5 | -0.1% | 295,300 |
| 2020/03/16 | 4,190 | 4,295 | 4,070 | 4,085 | -95 | -2.3% | 157,600 |
| 2020/03/13 | 4,070 | 4,240 | 3,945 | 4,180 | -310 | -6.9% | 261,000 |
| 2020/03/12 | 4,640 | 4,685 | 4,460 | 4,490 | -250 | -5.3% | 165,800 |
| 2020/03/11 | 4,825 | 4,880 | 4,720 | 4,740 | -90 | -1.9% | 163,300 |
| 2020/03/10 | 4,795 | 4,840 | 4,600 | 4,830 | -35 | -0.7% | 172,200 |
| 2020/03/09 | 4,975 | 5,000 | 4,825 | 4,865 | -255 | -5% | 80,100 |
| 2020/03/06 | 5,180 | 5,180 | 5,070 | 5,120 | -110 | -2.1% | 83,500 |
| 2020/03/05 | 5,290 | 5,310 | 5,190 | 5,230 | +20 | +0.4% | 118,300 |
| 2020/03/04 | 5,200 | 5,280 | 5,180 | 5,210 | -120 | -2.3% | 127,600 |
| 2020/03/03 | 5,500 | 5,540 | 5,320 | 5,330 | -60 | -1.1% | 154,500 |
| 2020/03/02 | 5,160 | 5,410 | 5,140 | 5,390 | +150 | +2.9% | 150,200 |
| 2020/02/28 | 5,210 | 5,250 | 5,170 | 5,240 | -170 | -3.1% | 219,000 |
| 2020/02/27 | 5,560 | 5,560 | 5,380 | 5,410 | -150 | -2.7% | 88,400 |
1251～
1300
件表示中 / 3724件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 380,900円 | -6.4% | -71.8% | 4.99% | 42.54倍 | 0.95倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| ジーエヌアイ | 374,500円 | +21.7% | +999.9% | 0.00% | 15.68倍 | 5.19倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
ＪＴ傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がＴＯＢ実施 |
| 東和薬品 | 294,700円 | +7.9% | -3.3% | 2.71% | 8.19倍 | 0.85倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 201,600円 | +3.1% | -6.5% | 2.38% | 9.35倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
